Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| R01CA233201 | An improved IL-24 gene-based therapeutic for cancer | 1 | 2023 |
| R01CA233749 | AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis | 1 | 2023 |
| R01CA235412 | Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression | 1 | 2023 |
| R01CA241600 | Clonal Reconstruction and Targeting of the Correa Sequence | 1 | 2023 |
| R01CA243445 | Nano-Engineered Lab-on-a-Chip for Assessing HuR-Regulated Exosomes for Cancer Monitoring and Targeted Therapy | 1 | 2023 |
| R01DK024031 | Pathobiology of Hepatic Epithelia | 1 | 2023 |
| R01DK081705 | Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy | 1 | 2023 |
| R01DK125396 | Investigating imitation SWI chromatin remodeling complexes in mammalian tissue regeneration | 1 | 2023 |
| R01EY031685 | Identification of gene regulatory networks that control proliferative and neurogenic competence in mammalian Müller glia | 1 | 2023 |
| R01GM114141 | Mechanisms mediating immune response upon sensing of nuclear viral DNA | 1 | 2023 |
| R01GM130935 | Analysis of non-canonical functions of microRNAs | 1 | 2023 |
| R01GM135362 | Selective mRNA translation in developmental disorders | 1 | 2023 |
| R01GM136974 | The Expedit-Isotopomeric CrossLinking Mass Spectrometry (Expedit-ICLMS) technology for mapping global and dynamic protein-protein interaction networks | 1 | 2023 |
| R01HD107798 | Impact of early microbial exposure on immune ontogeny | 1 | 2023 |
| R01HL149365 | Development of fetal hemoglobin inducers targeting epigenetic and oxidative stress mechanisms | 1 | 2023 |
| R01NS108796 | Dynamic interaction between HIV in the CNS and peripheral organs | 1 | 2023 |
| R03DK126729 | Age-specific differentiation of multipotent progenitors | 1 | 2023 |
| T32AI007334 | Molecular and Cellular Immunology | 1 | 2023 |
| T32DK007780 | Hematopoiesis Training Grant | 1 | 2023 |
| T32GM007250 | Medical Scientist Training Program | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=21